The Woodcliff Lake-based company boasts a robust pipeline and just added two commercialized products through its acquisition of Acacia Pharma. In short, Eagle is ready to soar.

Citius Pharmaceuticals Executive Chairman Leonard Mazur discusses the company's pipeline and the business climate for the industry in the state.

The incoming president and CEO of the New Jersey Bankers Association talks about how the organization will meet the challenges wrought by economic and geopolitical turmoil.

Michael Affuso brings a wealth of political know-how to his work at the NJBA, where he'll take over as president and CEO, replacing John McWeeney, who is retiring.

The CEO of Englewood Health discusses the implications of the court ruling blocking its deal with Hackensack Meridian and how the hospital and health care system will continue to serve an expanding number of communities, among other subjects.

The head of core molecular diagnostics and women's health and cancer at BD integrated diagnostic solutions discusses the company's new cervical cancer screening system and the importance of early detection.

A new study by research firm business.org ranks New Jersey smack in the middle of states on the issue of pay equity between men and women. How do our neighbors stack up?

BD’s Chris Beddard explains the advantages of the company’s new screening mechanism for cervical cancer and why it’s time to pay attention again.

The target develops products designed to improve care for patients undergoing significant treatments such as surgery, other invasive procedures or chemotherapy.

The CEO of OceanFirst Financial returns to discuss the outlook for inflation, hiring and the industries showing strength amid the turmoil.

Meet the men and women leading the industry that keeps New Jerseyans strong, active and full of life.

In a 34-page ruling, the panel found that the FTC was justified in seeking to stop the deal. The court noted that an expert advising the agency estimated that the hospitals would have been able to increase prices by $31 million after the combination.